Sectoral Asset Management Inc Tg Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$7.81 - $20.45 $3.12 Million - $8.18 Million	-399,949 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$15.2 - $35.51 $76,000 - $177,550	5,000 Added 1.27%	399,949 $7.6 Million
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $435,600 - $809,000	-20,000 Reduced 4.82%	394,949 $13.1 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $3.21 Million - $4.83 Million	-98,700 Reduced 19.22%	414,949 $16.1 Million
Q1 2021 May 14, 2021	BUY	$41.61 - $54.3 $12.8 Million - $16.7 Million	307,100 Added 148.68%	513,649 $24.8 Million
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $5.22 Million - $11.3 Million	206,549 New	206,549 $10.7 Million
Q4 2017 Feb 13, 2018	SELL	$7.35 - $12.3 $737,690 - $1.23 Million	-100,366 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$10.0 - $12.7 $1 Million - $1.27 Million	100,366	100,366 $1.19 Million

287

91.8M

1.9M

1.45M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.46B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.